Yu Zhang, Jun Liu, Sha Li, Jinhua Zhou, Jiushan Liu, Yan Huang
{"title":"ph触发CS@ZnO2纳米复合材料:自激活ROS生成有效的细菌根除。","authors":"Yu Zhang, Jun Liu, Sha Li, Jinhua Zhou, Jiushan Liu, Yan Huang","doi":"10.3389/fbioe.2025.1608188","DOIUrl":null,"url":null,"abstract":"<p><p>Functional nanomaterials based on reactive oxygen species (ROS) have attracted considerable attention in the treatment of bacterial infections, owing to their high sterilization efficiency and low tendency to induce drug resistance. Natural polymers, known for their excellent biocompatibility, have been widely used in the development of antibacterial dressings. In this study, chitosan-zinc peroxide composite dressing (CS@ZnO<sub>2</sub>) was synthesized using zinc acetate and chitosan as primary raw materials, and comprehensive characterizations were performed. Under the slightly acidic conditions of bacterial infections, CS@ZnO<sub>2</sub> could self-decompose to release H<sub>2</sub>O<sub>2</sub> and produce large amount of ROS, which would cause damage to bacteria. The <i>in vitro</i> antibacterial properties of CS@ZnO<sub>2</sub> were investigated using <i>Escherichia coli</i> (<i>E</i>. <i>coli</i>) and <i>Staphylococcus aureus</i> (<i>S</i>. <i>aureus</i>) as representative pathogens. The results demonstrated that CS@ZnO<sub>2</sub> exhibited potent antibacterial efficacy against both <i>S</i>. <i>aureus</i> and <i>E</i>. <i>coli</i>. This research provides an important theoretical foundation and technical support for the development of novel antibacterial materials, and has the potential to improve the efficacy of treatments for bacterial infections in the future.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1608188"},"PeriodicalIF":4.3000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129926/pdf/","citationCount":"0","resultStr":"{\"title\":\"pH-triggered CS@ZnO<sub>2</sub> nanocomposites: Self-activated ROS generation for efficient bacterial eradication.\",\"authors\":\"Yu Zhang, Jun Liu, Sha Li, Jinhua Zhou, Jiushan Liu, Yan Huang\",\"doi\":\"10.3389/fbioe.2025.1608188\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Functional nanomaterials based on reactive oxygen species (ROS) have attracted considerable attention in the treatment of bacterial infections, owing to their high sterilization efficiency and low tendency to induce drug resistance. Natural polymers, known for their excellent biocompatibility, have been widely used in the development of antibacterial dressings. In this study, chitosan-zinc peroxide composite dressing (CS@ZnO<sub>2</sub>) was synthesized using zinc acetate and chitosan as primary raw materials, and comprehensive characterizations were performed. Under the slightly acidic conditions of bacterial infections, CS@ZnO<sub>2</sub> could self-decompose to release H<sub>2</sub>O<sub>2</sub> and produce large amount of ROS, which would cause damage to bacteria. The <i>in vitro</i> antibacterial properties of CS@ZnO<sub>2</sub> were investigated using <i>Escherichia coli</i> (<i>E</i>. <i>coli</i>) and <i>Staphylococcus aureus</i> (<i>S</i>. <i>aureus</i>) as representative pathogens. The results demonstrated that CS@ZnO<sub>2</sub> exhibited potent antibacterial efficacy against both <i>S</i>. <i>aureus</i> and <i>E</i>. <i>coli</i>. This research provides an important theoretical foundation and technical support for the development of novel antibacterial materials, and has the potential to improve the efficacy of treatments for bacterial infections in the future.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1608188\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129926/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1608188\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1608188","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
pH-triggered CS@ZnO2 nanocomposites: Self-activated ROS generation for efficient bacterial eradication.
Functional nanomaterials based on reactive oxygen species (ROS) have attracted considerable attention in the treatment of bacterial infections, owing to their high sterilization efficiency and low tendency to induce drug resistance. Natural polymers, known for their excellent biocompatibility, have been widely used in the development of antibacterial dressings. In this study, chitosan-zinc peroxide composite dressing (CS@ZnO2) was synthesized using zinc acetate and chitosan as primary raw materials, and comprehensive characterizations were performed. Under the slightly acidic conditions of bacterial infections, CS@ZnO2 could self-decompose to release H2O2 and produce large amount of ROS, which would cause damage to bacteria. The in vitro antibacterial properties of CS@ZnO2 were investigated using Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) as representative pathogens. The results demonstrated that CS@ZnO2 exhibited potent antibacterial efficacy against both S. aureus and E. coli. This research provides an important theoretical foundation and technical support for the development of novel antibacterial materials, and has the potential to improve the efficacy of treatments for bacterial infections in the future.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.